Protalix BioTherapeutics

PLX

Börsenwert 213 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Federated Hermes Pittsburgh, Pennsylvania	46,9 Mio. $	+68.645 $	+1.471	+0,1 %
2	2 Allianz Asset Management Munich, Germany	34,3 Mio. $	-1,14 Mio. $	-24.354	-3 %
3	3 Baillie Gifford & Co Edinburgh, United Kingdom	26,9 Mio. $	-219.562 $	-4.705	-0,8 %
4	4 Camber Capital Management Boston, Massachusetts	9,16 Mio. $	–	–	–
5	5 BlackRock Advisors Wilmington, Delaware	8,21 Mio. $	–	–	–
6	DCM 6 DAFNA Capital Management Los Angeles, California	5,4 Mio. $	–	–	–
7	7 Fidelity Investments Boston, Massachusetts	5,25 Mio. $	–	–	–
8	GPP 8 Great Point Partners Greenwich, Connecticut	4,18 Mio. $	-409.911 $	-8.784	-9 %
9	9 Menora Mivtachim Holdings Ramat Gan, Israel	3,83 Mio. $	-956.645 $	-20.500	-20 %
10	10 Mivtachim The Workers Social Insurance Fund Tel Aviv, Israel	3,22 Mio. $	+638.759 $	+13.688	+24 %
11	11 State of Wisconsin Investment Board Madison, Wisconsin	2,06 Mio. $	–	–	–
12	12 BlackRock Group London, United Kingdom	2 Mio. $	–	–	–
13	13 BlackRock New York	1,68 Mio. $	–	–	–
14	14 State of New Jersey Common Pension Fund D Trenton, New Jersey	1,1 Mio. $	–	–	–
15	15 Susquehanna International Group Bala Cynwyd, Pennsylvania	847.000 $	-358.205 $	-7.676	-29 %
16	16 BNP Paribas Financial Markets Paris, France	682.214 $	+37.099 $	+795	+5 %
17	17 Deltec Asset Management New York	501.000 $	+510.848 $	+10.947	Neu
18	FRM 18 Fore Research & Management New York	458.000 $	-628.492 $	-13.468	-57 %
19	19 Vanguard Group Malvern, Pennsylvania	436.000 $	+88.385 $	+1.894	+25 %
20	20 Group One Trading Chicago, Illinois	343.000 $	+137.617 $	+2.949	+65 %
21	21 California Public Employees Retirement System Sacramento, California	341.000 $	–	–	–
22	22 BlueCrest Capital Management (UK) St. Peter Port, Guernsey	334.000 $	+340.659 $	+7.300	Neu
23	PVH 23 Psagot Value Holdings Tel Aviv, Israel	329.000 $	-11.900 $	-255	-3 %
24	24 Morgan Stanley New York	249.000 $	+241.961 $	+5.185	+1.942 %
25	25 Oppenheimer & Co New York	186.000 $	+45.032 $	+965	+31 %

Protalix BioTherapeutics PLX Börsenwert 213 Mio. $

Protalix BioTherapeutics

PLX

Börsenwert 213 Mio. $